Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-079759
Filing Date
2024-03-28
Accepted
2024-03-28 08:16:08
Documents
6
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 d813440ds8.htm S-8 33326
2 EX-5.1 d813440dex51.htm EX-5.1 6463
3 EX-23.1 d813440dex231.htm EX-23.1 3418
4 EX-FILING FEES d813440dexfilingfees.htm EX-FILING FEES 21963
5 GRAPHIC g813440dsp2.jpg GRAPHIC 10248
6 GRAPHIC g813440g0327073336011.jpg GRAPHIC 2755
  Complete submission text file 0001193125-24-079759.txt   79163
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278294 | Film No.: 24793642
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)